Celecoxib Enhances E1A-Induced Apoptosis in Breast Cancer Cells
Author Information
Author(s): Sugimoto Takeshi, Bartholomeusz Chandra, Tari Ana M, Ueno Naoto T
Primary Institution: The University of Texas M. D. Anderson Cancer Center
Hypothesis
Celecoxib would enhance E1A-induced apoptosis by suppressing Bcl-2 through suppressing COX-2 expression.
Conclusion
Celecoxib enhances E1A-induced apoptosis in breast cancer cells that express high levels of COX-2 protein, partly by blocking the production of PGE2 or PGF2α.
Supporting Evidence
- Celecoxib increased apoptosis in COX-2-overexpressing breast cancer cells.
- Blocking PGE2 or PGF2α improved cell viability in celecoxib-treated cells.
- COX-2 expression was highest in MDA-MB-231-E1A cells, which were more sensitive to celecoxib.
Takeaway
Celecoxib, a drug that reduces inflammation, helps a cancer treatment work better by making cancer cells die more easily.
Methodology
The study involved testing the effects of celecoxib on breast cancer cell lines with varying COX-2 expression levels, assessing cell viability and apoptosis through various assays.
Limitations
The study only examined one COX-2 inhibitor, celecoxib, and the level of E1A expression was not uniform among the cell lines.
Statistical Information
P-Value
0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website